{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:22:12Z","timestamp":1794007332039,"version":"4.8.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ijantimicag.2019.09.003","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T19:04:43Z","timestamp":1568228683000},"page":"105799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination"],"prefix":"10.1016","volume":"55","author":[{"given":"Mariana","family":"Castanheira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalitagauri M.","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn A.","family":"Messer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Rhomberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Pfaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0001","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101510","article-title":"Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004\u20132008","volume":"9","author":"Pfaller","year":"2014","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2019.09.003_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1439-0507.2008.01522.x","article-title":"Developments in the epidemiology of invasive fungal infections\u2014implications for the empiric and targeted antifungal therapy","volume":"51","author":"Hof","year":"2008","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0003","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1086\/529435","article-title":"Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit","volume":"46","author":"Chow","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0004","doi-asserted-by":"crossref","first-page":"e01564","DOI":"10.1128\/JCM.01564-17","article-title":"Update from a 12-year nationwide fungemia surveillance: increasing intrinsic and acquired resistance causes concern","volume":"56","author":"Astvad","year":"2018","journal-title":"J Clin Microbiol"},{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2019.09.003_bib0005","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/jac\/dkx444","article-title":"Changes in the epidemiological landscape of invasive candidiasis","volume":"73","author":"Lamoth","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0006","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1128\/JCM.01283-12","article-title":"Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011","volume":"50","author":"Lockhart","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0007","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/jac\/dkx047","article-title":"Changing epidemiology of candidaemia in Australia","volume":"72","author":"Chapman","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0008","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10096-016-2841-3","article-title":"Epidemiology and reporting of candidaemia in Belgium: a multi-centre study","volume":"36","author":"Trouve","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0009","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s12879-016-1767-9","article-title":"Outbreak of candidemia caused by fluconazole resistant Candida parapsilosis strains in an intensive care unit","volume":"16","author":"Pinhati","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0010","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1128\/JCM.43.6.2729-2735.2005","article-title":"Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit","volume":"43","author":"Sarvikivi","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0011","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1093\/jac\/dkw091","article-title":"Emergence of azole-resistant Candida parapsilosis causing bloodstream infection: results from laboratory-based sentinel surveillance in South Africa","volume":"71","author":"Govender","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0012","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/cid\/cis697","article-title":"Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008\u20132011","volume":"55","author":"Cleveland","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0013","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11046-014-9831-8","article-title":"The A395T mutation in ERG11 gene confers fluconazole resistance in Candida tropicalis causing candidemia","volume":"179","author":"Tan","year":"2015","journal-title":"Mycopathologia"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0014","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jmii.2013.08.017","article-title":"Changing epidemiology of candidemia in a medical center in middle Taiwan","volume":"48","author":"Hii","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0015","first-page":"988","article-title":"Pan-azole-resistant Candida tropicalis carrying homozygous erg11 mutations at position K143R: a new emerging superbug?","volume":"72","author":"Xisto","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0016","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1086\/502294","article-title":"Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis","volume":"25","author":"Yang","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"Suppl 3","key":"10.1016\/j.ijantimicag.2019.09.003_bib0017","doi-asserted-by":"crossref","first-page":"S445","DOI":"10.1093\/infdis\/jix131","article-title":"Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment","volume":"216","author":"Arendrup","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0018","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/AAC.01674-13","article-title":"Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates","volume":"58","author":"Castanheira","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 6","key":"10.1016\/j.ijantimicag.2019.09.003_bib0019","doi-asserted-by":"crossref","first-page":"S612","DOI":"10.1093\/cid\/civ791","article-title":"Echinocandin resistance in Candida","volume":"61","author":"Perlin","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0020","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1128\/JCM.00308-13","volume":"51","author":"Pfaller","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0021","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofv163","article-title":"Epidemiology and risk factors for echinocandin nonsusceptible Candida glabrata bloodstream infections: data from a large multisite population-based candidemia surveillance program, 2008\u20132014","volume":"2","author":"Vallabhaneni","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0022","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0023","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1128\/JCM.06112-11","article-title":"Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata","volume":"50","author":"Pfaller","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0024","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1128\/AAC.03255-14","article-title":"The role of FKS mutations in C. glabrata: MIC values, echinocandin resistance and multidrug resistance","volume":"58","author":"Pham","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0025","doi-asserted-by":"crossref","first-page":"e00906","DOI":"10.1128\/AAC.00906-17","article-title":"Monitoring antifungal resistance in a global collection of invasive yeasts and moulds: application of CLSI epidemiological cutoff values and whole genome sequencing analysis for detection of azole resistance in Candida albicans","volume":"61","author":"Castanheira","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0026","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11046-012-9551-x","article-title":"Significance of molecular identification and antifungal susceptibility of clinically significant yeasts and moulds in a global antifungal surveillance program","volume":"174","author":"Pfaller","year":"2012","journal-title":"Mycopathologia"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0027","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/JCM.01686-12","article-title":"Candida guilliermondii and other species of Candida misidentified as Candida famata: assessment by Vitek2, ITS sequence analysis and matrix-assisted laser desorption ionization\u2013time of flight mass spectrometry in two global surveillance programs","volume":"51","author":"Castanheira","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0028","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts","year":"2017"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0029","series-title":"Performance standards for antifungal susceptibility testing of yeasts","year":"2017"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0030","series-title":"Epidemiological cutoff values for antifungal susceptibility testing","year":"2016"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0031","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; fourth informational supplement","year":"2012"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0032","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/IDR.S118892","article-title":"Fluconazole resistance in Candida species: a current perspective","volume":"10","author":"Berkow","year":"2017","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0033","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.diagmicrobio.2016.02.009","article-title":"Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013)","volume":"85","author":"Castanheira","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0034","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1128\/AAC.00477-13","article-title":"Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications","volume":"57","author":"Forastiero","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0035","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.3201\/eid2409.180625","article-title":"Fluconazole-resistant Candida parapsilosis bloodstream isolates with Y132F mutation in ERG11 gene, South Korea","volume":"24","author":"Choi","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0036","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1128\/AAC.01177-15","article-title":"Candida parapsilosis resistance to fluconazole: molecular mechanisms and in vivo impact in infected Galleria mellonella larvae","volume":"59","author":"Souza","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0037","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/jac\/dky122","article-title":"CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates","volume":"73","author":"Rizzato","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.003_bib0038","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/jac\/dks481","article-title":"Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China","volume":"68","author":"Jiang","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"10.1016\/j.ijantimicag.2019.09.003_bib0039","doi-asserted-by":"crossref","first-page":"ii13","DOI":"10.1093\/jac\/dkw392","article-title":"The current treatment landscape: candidiasis","volume":"71","author":"Bassetti","year":"2016","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919302468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919302468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:35:25Z","timestamp":1760376925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857919302468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0924857919302468"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.09.003","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105799"}}